Page last updated: 2024-10-31

molsidomine and Carcinoma, Lewis Lung

molsidomine has been researched along with Carcinoma, Lewis Lung in 1 studies

Molsidomine: A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS.
molsidomine : A member of the class of oxadiazoles that is 1,2,3-oxadiazole substituted by morpholin-4-yl and (ethoxycarbonyl)azanidyl groups at positions 3 and 5, respectively. It is used as a vasodilator drug for the treatment of myocardial ischemic syndrome and congestive heart failure.

Carcinoma, Lewis Lung: A carcinoma discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. (From Cancer Chemother Rep 2 1972 Nov;(3)1:325) It is also called 3LL and LLC and is used as a transplantable malignancy.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lu, T1
Ramakrishnan, R1
Altiok, S1
Youn, JI1
Cheng, P1
Celis, E1
Pisarev, V1
Sherman, S1
Sporn, MB1
Gabrilovich, D1

Other Studies

1 other study available for molsidomine and Carcinoma, Lewis Lung

ArticleYear
Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice.
    The Journal of clinical investigation, 2011, Volume: 121, Issue:10

    Topics: Animals; Carcinoma, Lewis Lung; Cell Line, Tumor; Female; Humans; Inflammation Mediators; Interleuki

2011